ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,192,386 | -8.3% | 42,570 | +2.4% | 0.01% | -9.1% |
Q2 2023 | $1,300,703 | -3.1% | 41,556 | -12.7% | 0.01% | -8.3% |
Q1 2023 | $1,342,126 | +10.8% | 47,610 | +2.7% | 0.01% | 0.0% |
Q4 2022 | $1,211,073 | +22.1% | 46,348 | +4.4% | 0.01% | +20.0% |
Q3 2022 | $992,000 | -24.2% | 44,411 | +1.2% | 0.01% | -23.1% |
Q2 2022 | $1,308,000 | +13.7% | 43,894 | +0.4% | 0.01% | +44.4% |
Q1 2022 | $1,150,000 | +13.9% | 43,711 | +0.7% | 0.01% | +12.5% |
Q4 2021 | $1,010,000 | -25.1% | 43,422 | -0.6% | 0.01% | -27.3% |
Q3 2021 | $1,348,000 | +27.0% | 43,706 | +1.0% | 0.01% | +22.2% |
Q2 2021 | $1,061,000 | +22.7% | 43,285 | -6.6% | 0.01% | +12.5% |
Q1 2021 | $865,000 | -6.0% | 46,329 | +0.4% | 0.01% | 0.0% |
Q4 2020 | $920,000 | +15.9% | 46,123 | -3.7% | 0.01% | 0.0% |
Q3 2020 | $794,000 | +14.9% | 47,896 | +34.5% | 0.01% | -20.0% |
Q2 2020 | $691,000 | +29.6% | 35,614 | -3.7% | 0.01% | +11.1% |
Q1 2020 | $533,000 | – | 36,981 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |